Skip to main content
Year archive

AFT Pharmaceuticals Limited — 2020 filings

All 64 regulatory filings released by AFT Pharmaceuticals Limited (AFT) in 2020, sourced directly from the official regulator.

64 Filings
2020 Period
2020 filings (64)
Filing Released Lang
AFT builds North American momentum
Board/Management Information
2020-12-22 English
AFT determination of Anita Baldauf independence
Board/Management Information
2020-12-15 English
Issue of ordinary shares
Share Issue/Capital Change
2020-11-25 English
FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2020
Interim / Quarterly Report
2020-11-18 English
AFT opening European office, signs new partners for MXG
Capital/Financing Update
2020-11-17 English
AFT welcomes US FDA Complete Response Letter
Regulatory Filings
2020-11-08 English
AFT appoints Anita Baldauf as a director
Board/Management Information
2020-11-03 English
AFT and Setek sign supply agreement
Capital/Financing Update
2020-11-03 English
Maxigesic IV(R) distribution deals signed in UK and Hong Kong
Capital/Financing Update
2020-11-02 English
kiwihealth flagship store launches on Tmall Global
Regulatory Filings
2020-10-22 English
AFT to announce half year interim results on Nov 19 2020
Report Publication Announcement
2020-10-13 English
SPH Notice – Bell Potter Securities Limited
Major Shareholding Notification
2020-09-21 English
SPH Notice – Forsyth Barr Limited
Major Shareholding Notification
2020-09-16 English
ASM Results
Declaration of Voting Results & Voting Rights Announcements
2020-09-08 English
ASM Presentation and Chair’s address
AGM Information
2020-09-08 English
Arrangements for the Adjourned 2020 Annual Meeting
Regulatory Filings
2020-08-23 English
Issue of ordinary shares
Share Issue/Capital Change
2020-08-13 English
Adjournment of 2020 Annual Meeting
Regulatory Filings
2020-08-11 English
Disclosure of Directors and Senior Managers Relevant Intere
Major Shareholding Notification
2020-08-10 English
Conversion of redeemable preference shares
Share Issue/Capital Change
2020-08-07 English
Maxigesic IV(R) licensed in six new European nations
Capital/Financing Update
2020-07-29 English
New Zealand codeine restrictions set for November
Regulatory Filings
2020-07-28 English
Notice of Annual Meeting of Shareholders 2020
AGM Information
2020-07-14 English
RooLife ASX announcement
Regulatory Filings
2020-07-10 English
Disclosure of Directors and Senior Managers Relevant Intere
Director's Dealing
2020-07-02 English
Issue of ordinary shares
Share Issue/Capital Change
2020-07-02 English
AFT Pharmaceuticals Share Purchase Plan Oversubscribed
Capital/Financing Update
2020-06-30 English
Disclosure of Directors and Senior Managers Relevant Intere
Director's Dealing
2020-06-30 English
Disclosure of Directors and Senior Managers Relevant Intere
Director's Dealing
2020-06-26 English
Nathan Hukill resigns from AFT’S Board
Board/Management Information
2020-06-22 English
Disclosure of Directors and Senior Managers Relevant Intere
Director's Dealing
2020-06-17 English
SPH Notice – Bell Potter Securities Limited
Major Shareholding Notification
2020-06-15 English
SPH Notice – Forsyth Barr, Forsyth Barr Group and FBIM
Major Shareholding Notification
2020-06-15 English
AFT announces opening of Share Purchase Plan
Capital/Financing Update
2020-06-15 English
SPH Notice – The CRG Persons
Major Shareholding Notification
2020-06-15 English
SPH Notice – Hartley Campbell Atkinson and Colin McKay
Major Shareholding Notification
2020-06-15 English
Issue of ordinary shares
Share Issue/Capital Change
2020-06-15 English
AFT Limited (“AFT”) – Trading Halt of Securities Lifted
Regulatory Filings
2020-06-10 English
AFT announces successful completion of Placement
Capital/Financing Update
2020-06-10 English
SPH Notice – Forsyth Barr Group Limited
Regulatory Filings
2020-06-10 English
SPH Notice – Bell Potter Securities Limited
Regulatory Filings
2020-06-10 English
NZXR waiver from LR 5.2
Regulatory Filings
2020-06-10 English
SPH Notice – AF Trust
Regulatory Filings
2020-06-10 English
SPH Notice – CRG Persons
Regulatory Filings
2020-06-10 English
AFT Limited (“AFT”) – Trading Halt of Securities
Capital/Financing Update
2020-06-10 English
AFGT annoucements capital raising to support liquidity
Capital/Financing Update
2020-06-10 English
Dispute with PBL Solutions Limited
Legal Proceedings Report
2020-06-05 English
Annual Meeting and Closing Date for Director Nominations
AGM Information
2020-06-04 English
AFT secures Maxigesic IV(R) distribution in four European
Capital/Financing Update
2020-06-03 English
Capital Change Notice – Issue of ordinary shares
Share Issue/Capital Change
2020-05-26 English
Amended SPH Notice – The CRG Persons
Major Shareholding Notification
2020-05-21 English
SPH Notice – The CRG Persons
Major Shareholding Notification
2020-05-20 English
Conversion of redeemable preference shares
Share Issue/Capital Change
2020-05-19 English
AFT FY2020 Results annoucement
Annual Report
2020-05-19 English
AFT to announce full year results on May 20 2020
Report Publication Announcement
2020-05-04 English
D&O Ongoing Disclosure – Malcolm Tubby
Director's Dealing
2020-04-23 English
Capital Change Notice – Issue of ordinary shares
Share Issue/Capital Change
2020-04-23 English
RooLife ASX announcement
Regulatory Filings
2020-04-06 English
AFT finalises refinancing and gives trading update
Capital/Financing Update
2020-03-22 English
Market Trading Update
Regulatory Filings
2020-03-10 English
AFT on track to refinance CRG term loan facility
Capital/Financing Update
2020-02-26 English
AFT licenses Maxigesic(R) IV in 21 new countries
Capital/Financing Update
2020-02-04 English
AFT licenses Maxigesic(R) IV in 21 new countries
Capital/Financing Update
2020-02-04 English
AFT notes Maxigesic(R) sales estimates in new market research
Regulatory Filings
2020-01-22 English